Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective...

Area of Science:

• Plastic Surgery
• Biomaterials Science

Background:

• Lightweight breast implants (B-Lite) utilize air-filled microspheres to reduce weight by up to 30% while maintaining mechanical properties.
• Limited long-term prospective data exists for B-Lite implants in primary breast augmentation.

Purpose of the Study:

• Evaluate the clinical performance, safety, patient satisfaction, and quality of life (QoL) following primary augmentation using B-Lite implants.
• Assess key endpoints including bra-cup increase, adverse events, and QoL metrics.

Main Methods:

• A multicenter, prospective, single-arm postmarketing clinical follow-up study.
• Enrolled 101 female patients (18-60 years) undergoing bilateral primary breast augmentation with B-Lite implants.
• Primary endpoint: ≥1 bra-cup increase at 12 months; secondary endpoints: QoL, satisfaction, and adverse events (AEs).

Main Results:

• 92% of patients achieved at least a one-cup increase at 12 months.
• No cases of capsular contracture (Baker III-IV), rupture, or breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) were reported.
• High patient satisfaction (98.6%) and surgeon satisfaction (97-100%) were observed, with minimal adverse events, predominantly transient sensory changes.

Conclusions:

• Lightweight B-Lite implants demonstrate high effectiveness and a favorable safety profile for primary breast augmentation.
• The study indicates very high patient satisfaction and sustained quality of life improvements.
• Long-term follow-up up to 5 years supports the use of B-Lite implants.